Symposium 18: Drug therapy available in Argentina

Abstract

Understanding the physiology of body weight control, which defends the body against weight loss and drives the recovery of lost weight, has shown great advances in the therapeutic goals of a chronic disease such as obesity. The use of drugs for the treatment of obesity is limited by modest perceived efficacy, safety concerns, resistance from patients and physicians, and lack of reimbursement by public and private insurers. These are barriers in drug treatment that must be broken down 1. Guidelines from the American Heart Association, American College of Cardiology, The Obesity Society recommend that pharmacotherapy should be indicated as an adjunct to diet and exercise in people with a Body Mass Index ≥30 kg/m2 or ≥27 kg/m2 with obesity-related comorbidities 2.

Keywords

• obesidad
• fármacos